PRAKASH MASAND to Depression
This is a "connection" page, showing publications PRAKASH MASAND has written about Depression.
Connection Strength
0.357
-
Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability. Expert Opin Drug Saf. 2022 Jun; 21(6):725-732.
Score: 0.099
-
Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials. J Affect Disord. 2019 10 01; 257:600-606.
Score: 0.082
-
Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression. J Affect Disord. 2019 Apr 15; 249:410-417.
Score: 0.080
-
A review of current evidence for acetyl-l-carnitine in the treatment of depression. J Psychiatr Res. 2014 Jun; 53:30-7.
Score: 0.056
-
Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial. Clin Neuropharmacol. 2009 Mar-Apr; 32(2):85-8.
Score: 0.040